Carregant...

Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissues

Survivin overexpression is associated with poor prognosis of human gastric cancer, and is a target for gastric cancer therapy. YM155 is originally identified as a specific inhibitor of survivin. In this study, we investigated the antitumor effect of YM155 on human gastric cancer. Our results showed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Cheng, Xiao Jiao, Lin, Jia Cheng, Ding, Yan Fei, Zhu, Liming, Ye, Jing, Tu, Shui Ping
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872771/
https://ncbi.nlm.nih.gov/pubmed/26771139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6898
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!